Here are 1-3 brief analogies for Privia Health (PRVA):

• Shopify for doctor's offices: Just as Shopify provides a comprehensive platform and tools for small businesses to run their e-commerce stores, Privia Health offers a full suite of technology and services (EHR, revenue cycle management, managed care contracting) to help independent physician groups run their practices more efficiently and profitably.
• Salesforce for medical practices: Similar to how Salesforce provides cloud-based solutions to manage customer relationships and streamline business operations for various industries, Privia Health delivers an integrated platform and services designed to optimize clinical workflows, financial performance, and patient engagement for healthcare providers.

• Physician Enablement & Practice Management Services: Privia Health provides comprehensive administrative, operational, and financial support to physician groups, helping them manage their practices efficiently.
• Value-Based Care Solutions: The company enables healthcare providers to transition to and succeed in value-based care models through population health management, care coordination, and risk management programs.
• Integrated Technology & Data Analytics: Privia Health offers a suite of technology solutions, including electronic health record optimization, patient engagement platforms, and data analytics to enhance clinical and financial performance.

Privia Health (PRVA) Major Customers

Privia Health (PRVA) sells primarily to other companies. Its business model involves partnering with and enabling independent physician groups and entering into value-based care arrangements with various health plans.

According to Privia Health's financial filings (e.g., 2023 10-K), no individual payor (health plan) accounted for more than 10% of its total revenues, indicating a diversified customer base and the absence of a single "major customer" by revenue concentration. Similarly, their network consists of numerous independent physician groups, none of which individually represent a dominant portion of their revenue.

Therefore, while specific "major customer companies" cannot be named due to revenue diversification, Privia Health's customers broadly fall into two categories of companies:

• Independent Physician Groups and Practices: These are the medical groups, individual physicians, and clinical practices that join the Privia network to leverage its technology, practice management services, and value-based care contracting capabilities. These are typically local or regional entities rather than large public companies.
• Health Plans and Payors: Privia Health partners with various national and regional health insurance companies and managed care organizations to implement value-based care programs. These partnerships are crucial for shared savings and quality incentives. Examples of major health plans that Privia Health typically works with across its markets include those owned by, but not limited to:
  • UnitedHealth Group (NYSE: UNH)
  • Elevance Health (NYSE: ELV)
  • CVS Health (which owns Aetna) (NYSE: CVS)
  • Humana (NYSE: HUM)
  • Cigna Group (NYSE: CI)
  • Centene Corporation (NYSE: CNC)

  It is important to note that while Privia Health collaborates with these types of major health plans, none individually constitute a "major customer" by revenue concentration based on Privia's public disclosures.

Parth Mehrotra, Chief Executive Officer
Parth Mehrotra became the Chief Executive Officer of Privia Health after serving as President and Chief Operating Officer for over seven years. In his current role, he oversees company efforts related to growth, financial and operational efficiency across all markets, shared corporate functions, and Privia's business development efforts. He is also responsible for setting corporate strategy and leading Privia's technology innovation. Prior to joining Privia, he served as Chief Operating Officer of Brighton Health Group, which was Privia Health's former parent company. Before that, Mr. Mehrotra was a Senior Financial Officer at athenahealth and a member of the Healthcare Investment Banking group at Goldman Sachs for seven years, where he was involved in the athenahealth IPO.

David Mountcastle, Executive Vice President & Chief Financial Officer
David Mountcastle has extensive experience in both the healthcare and technology industries, working with companies ranging from startups to large, publicly traded enterprises. Before joining Privia Health, he was the Chief Financial Officer for Brainware, Inc., which he helped grow from a startup to its acquisition by Lexmark International for more than $150 million. Prior to that, Mr. Mountcastle was the Controller/Director of Finance for VT iDirect Technologies, where he helped guide the company from a startup to a strategic exit for its investors. Earlier in his career, he served as the Controller for HealthSpring Inc., which was later sold to United HealthCare, and also as the CFO for Southern Health.

Shawn Morris, Board Member (former CEO)
Shawn Morris previously served as the Chief Executive Officer of Privia Health from 2018 to 2023 and is currently a member of its board of directors. During his tenure as CEO, Privia Health completed its initial public offering in 2021. Prior to joining Privia Health, Mr. Morris was the President and Chief Operating Officer of Cigna-HealthSpring, a Cigna company, from 2016 to 2018. From 2010 to 2016, he held various leadership roles at Cigna-HealthSpring, including Chief Operating Officer, President of Development & Innovation, and Executive Vice President, overseeing the financial and operational performance of Cigna's Medicare Advantage business. Before his time at HealthSpring, Mr. Morris held leadership positions managing physician-led IPAs and a multi-specialty medical group, and began his career as a public accountant working with physician practices.

David Rothenberg, Co-Founder
David Rothenberg is a co-founder of Privia Health and has been a healthcare entrepreneur for over 20 years. He served as President of Privia for more than eight years, leading sales, marketing, and growth initiatives for the company. Mr. Rothenberg also co-founded MDLinx, a physician portal and doctor-focused market research company that was subsequently acquired by a division of Sony.

Chris Voigt, Executive Vice President & Chief Technology Officer
Chris Voigt serves as the Executive Vice President and Chief Technology Officer of Privia Health, bringing over 14 years of experience in healthcare interoperability. Before his role at Privia, he led corporate development for MobileMD, a health information exchange service provider that was acquired by Siemens in 2011. He also previously headed the U.S. HIE practice for systems integrator CGI.

The accelerated trend of large healthcare organizations (payers, pharmacy chains, and tech giants such as CVS/Aetna, Amazon, and UnitedHealth Group's Optum) acquiring or building out extensive primary care and specialty provider networks. These entities are creating highly integrated healthcare ecosystems, often combining insurance, pharmacy, and direct provider services with advanced digital health platforms. This development creates direct competition to independent physician practices—Privia Health's core partners—on a significant scale, leveraging greater capital, integrated data, and streamlined patient pathways. Examples like CVS's acquisition of Oak Street Health and Amazon's acquisition of One Medical underscore this strategic shift, which actively diminishes the market for independent practices and challenges the value proposition of companies that enable physicians to remain independent within a fragmented system.

Privia Health (PRVA) operates in the U.S. healthcare market, primarily offering physician enablement and value-based care solutions. The addressable markets for these main product and service categories are substantial within the United States.

• Physician Enablement Services: The U.S. physician enablement services market is estimated to be between $20 billion and $40 billion. A segment within this, the practice management system market, is projected to grow from $6.02 billion in 2024 to $10.1 billion by 2030 in the U.S. More broadly, the physician practice management market in North America, which holds a major revenue share, was estimated at US$118.9 billion in 2023 and is projected to reach US$291.7 billion by 2034, growing at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2034.

• Value-Based Healthcare Services: The U.S. value-based healthcare service market size was valued at approximately USD 4.01 trillion in 2024 and is expected to grow at a CAGR of 7.4% from 2025 to 2030. Other estimates place the U.S. value-based healthcare service market size at USD 3.6 trillion in 2023, with an anticipated CAGR of 6.2% from 2024 to 2032. The market is projected to reach roughly USD 6.92 trillion by 2034, with a CAGR of 6.66% from 2025 to 2034. A significant component of this, the accountable care organization (ACO) segment, held a revenue of approximately USD 1.3 trillion in the U.S. in 2023.

Privia Health (NASDAQ: PRVA) is expected to drive future revenue growth over the next 2-3 years through several key strategies:

1. Growth in Implemented Providers: Privia Health continues to expand its network by adding new healthcare providers. In Q3 2025, the company reported a 13.1% year-over-year increase in implemented providers, reaching 5,250. This growth is a consistent driver of platform revenue and is projected to increase by approximately 11.2% year-over-year to 5,325 by the end of 2025.
2. Expansion of Value-Based Care (VBC) Attributed Lives: The company is significantly increasing its participation and success in value-based care models. Privia Health expanded its value-based attributed lives to 1,406,000 in Q3 2025, a 12.8% increase, driven by strong performance in programs like the Medicare Shared Savings Program (MSSP) and other VBC arrangements. The company anticipates attributed lives growth of approximately 12.5% in 2025.
3. Strategic Acquisitions: Privia Health is leveraging acquisitions to accelerate growth, notably with the definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health. This acquisition, expected to close in Q4 2025 for $100 million in cash plus an earn-out, is projected to add over 120,000 value-based care attributed lives, expanding Privia's total VBC attributed lives to over 1.5 million and contributing positively to adjusted EBITDA in 2026.
4. Entry into New Geographic Markets: Geographic expansion is a critical component of Privia's growth strategy. The company currently operates in 15 states and the District of Columbia. New market entries, such as Arizona, have contributed to increased practice collections, and management views entering new markets as key to expanding its national footprint.
5. Same-Store Growth and Increased Utilization: Beyond adding new providers and markets, Privia Health is experiencing growth within its existing practices. The company has reported continued strength in "same-store growth" and higher utilization trends, indicating that existing patient panels and services are generating increased revenue. This reflects momentum across the business and contributes to overall revenue growth and margin expansion.

Share Repurchases

• Privia Health has not reported significant share repurchase programs or authorizations over the last 3-5 years. The 3-year average share buyback ratio indicates a net issuance of shares.

Share Issuance

• Privia Health went public in May 2021 through an Initial Public Offering (IPO), offering 22.4 million shares at $23 per share, aiming to raise approximately $516 million. The gross proceeds to Privia Health from this offering were expected to be about $64.4 million.
• As of October 31, 2025, the company had 123,001,529 shares of common stock outstanding.
• The company has issued common stock through the exercise of stock options and the vesting of restricted stock units.

Outbound Investments

• In September 2025, Privia Health signed an agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. for $100 million in cash, with a potential earn-out of up to $13 million. This acquisition is expected to close in the fourth quarter of 2025 and aims to add over 120,000 value-based care attributed lives.
• In the second quarter of 2025, Privia Health deployed $95 million for an IMS transaction in Arizona, which involved adding $64.4 million of payer/physician network intangibles and $30.6 million of goodwill.

Capital Expenditures

• Privia Health anticipates "de minimis capital expenditures" for the full-year 2025.
• At the time of its IPO in 2021, the company stated that a portion of the net proceeds would be used for capital expenditures, in addition to other general corporate purposes such as working capital, research and development, and business development.